Tandem Diabetes Care, Inc.
TNDM
$21.55
-$0.04-0.19%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.93% | 17.87% | 25.84% | 27.65% | 25.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.93% | 17.87% | 25.84% | 27.65% | 25.74% |
| Cost of Revenue | 4.02% | 9.80% | 17.23% | 20.25% | 18.58% |
| Gross Profit | 11.53% | 26.00% | 34.79% | 35.28% | 33.15% |
| SG&A Expenses | 11.36% | 14.79% | 19.49% | 18.75% | 14.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.15% | 10.50% | 16.82% | 18.76% | 16.75% |
| Operating Income | 21.19% | 35.89% | 34.10% | 31.94% | 30.43% |
| Income Before Tax | -117.99% | -66.35% | -54.14% | -28.07% | 58.29% |
| Income Tax Expenses | 6.81% | -143.84% | -41.27% | 79.53% | 76.28% |
| Earnings from Continuing Operations | -113.18% | -60.41% | -50.52% | -29.98% | 56.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -113.18% | -60.41% | -50.52% | -29.98% | 56.86% |
| EBIT | 21.19% | 35.89% | 34.10% | 31.94% | 30.43% |
| EBITDA | 26.74% | 41.68% | 39.26% | 36.77% | 34.90% |
| EPS Basic | -108.59% | -57.02% | -47.67% | -28.22% | 57.18% |
| Normalized Basic EPS | -2.66% | 25.04% | 29.06% | 32.15% | 33.44% |
| EPS Diluted | -108.59% | -57.02% | -47.67% | -28.22% | 57.18% |
| Normalized Diluted EPS | -2.65% | 25.03% | 29.05% | 32.14% | 33.43% |
| Average Basic Shares Outstanding | 2.80% | 2.23% | 1.58% | 0.86% | 0.74% |
| Average Diluted Shares Outstanding | 2.71% | 2.31% | 1.67% | 0.94% | 0.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |